Chronic Migraine Clinical Trials

154 clinical trials for Chronic Migraine across international registries, including 40 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Responding With Evidence and Access for Childhood Headaches — RECRUITING · NA
• The RECLAIM Study. — RECRUITING · NA
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults — RECRUITING · PHASE2
• Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine — RECRUITING
• BOTOX® vs. XEOMIN® for Chronic Migraine — RECRUITING · PHASE3
• Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig) — RECRUITING · PHASE2
• A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years — RECRUITING · PHASE3
• A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine — RECRUITING · PHASE3
• Mind Body Balance for Pediatric Migraine — RECRUITING · NA
• i-NEED: NEw migrainE Drugs Database — RECRUITING
• Determining the Utility of a Behavioral Intervention in Chronic Migraine — RECRUITING · NA
• Study on 30 Outpatients With Chronic Migraine Treated With Well-Being Therapy or With a Control Therapy — RECRUITING · NA
• Cannabis for the Prophylactic Treatment of Migraine — RECRUITING · PHASE2
• Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo) — RECRUITING · NA
• Gepant treAtments: EffectIveNess and tolERability (GAINER) — RECRUITING
• Laser Acupuncture for Chronic Migraine — RECRUITING · NA
• Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine — RECRUITING · NA
• Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA — RECRUITING
• A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE ESCALATION AND DOSE FINDING PHASE II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF IPN10200 IN THE PREVENTION OF EPISODIC OR CHRONIC MIGRAINE IN ADULTS (MERANTI) — RECRUITING · PHASE2
• Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients — RECRUITING
• Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics — RECRUITING
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, CLINICAL TRIAL WITH EXTENSION PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF XEOMIN® INJECTIONS FOR THE PREVENTION OF CHRONIC MIGRAINE — RECRUITING · PHASE3
• A Study Investigating Peripheral Cryoneurolysis in Adults With Chronic Migraine — RECRUITING · NA
• Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial — RECRUITING · PHASE2
• Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine — RECRUITING · NA
• A PHASE 3, MULTICENTER, 12-WEEK, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ATOGEPANT FOR THE PREVENTIVE TREATMENT OF CHRONIC MIGRAINE IN PEDIATRIC SUBJECTS 12 TO 17 YEARS OF AGE — RECRUITING · PHASE3
• Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult — RECRUITING · NA
• CGRP Inhibition, Autonomic Function, and Migraine — RECRUITING
• Efficacy of Nerve Block Versus Botox in Chronic Migraine Management — RECRUITING · NA
• Biochemical Profiling of Migraine Patients — RECRUITING
• Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments — RECRUITING
• Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments — RECRUITING
• A PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, PARALLEL-GROUP STUDY WITH EXTENSION PHASE TO EVALUATE THE EFFICACY AND SAFETY OF DYSPORT® FOR THE PREVENTION OF CHRONIC MIGRAINE IN ADULT PARTICIPANTS — RECRUITING · PHASE3
• LONG TERM, OPEN LABEL (DOSE BLINDED), EXTENSION STUDY OF EPTINEZUMAB IN CHILDREN AND ADOLESCENTS WITH CHRONIC OR EPISODIC MIGRAINE — RECRUITING
• INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF IV EPTINEZUMAB IN ADOLESCENTS (12-17 YEARS) FOR THE PREVENTIVE TREATMENT OF CHRONIC MIGRAINE — RECRUITING
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY COMPARING THE EFFICACY, SAFETY, AND TOLERABILITY OF SUBCUTANEOUS ADMINISTRATION OF FREMANEZUMAB VERSUS PLACEBO FOR THE PREVENTIVE TREATMENT OF CHRONIC MIGRAINE IN PEDIA — RECRUITING
• A MULTICENTER, OPEN-LABEL STUDY EVALUATING LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF MONTHLY SUBCUTANEOUS ADMINISTRATION OF FREMANEZUMAB FOR THE PREVENTIVE TREATMENT OF EPISODIC AND CHRONIC MIGRAINE IN PEDIATRIC PATIENTS 6 TO 17 YEARS OF AGE — RECRUITING
• "A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ERENUMAB IN CHILDREN (6 TO < 12 YEARS) AND ADOLESCENTS (12 TO < 18 YEARS) WITH CHRONIC MIGRAINE (OASIS PEDIATRIC [CM])." — RECRUITING · PHASE3
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF 2 DOSE REGIMENS OF SUBCUTANEOUS ADMINISTRATION OF TEV-48125 VERSUS PLACEBO FOR THE PREVENTIVE TREATMENT OF CHRONIC MIGRAINE — RECRUITING
• AN OPEN-LABEL EXTENSION (OLE) STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY OF AMG 334 — RECRUITING
• A clinical trial of TEV-48125 versus Placebo for the Preventive Treatment of Chronic Migraine — COMPLETED · PHASE3
• Mechanism-Based Cervical Rehabilitation for Chronic Migraine — NOT_YET_RECRUITING · NA
• A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial with extension period to evaluate the efficacy and safety of Xeomin® injections for the prevention of chronic migraine (MINT-C) — TERMINATED · PHASE3
• A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Chronic Migraine in Pediatric Subjects 12 to 17 Years of Age — TERMINATED · PHASE3
• A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults — ACTIVE_NOT_RECRUITING · PHASE3
• C4951013 - AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE — TERMINATED · PHASE3
• First Evaluation of a Craniofacial Nerve Stimulation System in Chronic Migraine — ACTIVE_NOT_RECRUITING · NA
• Evolution of the Cognitive Profile and Quality of Life of Adult Patients Suffering From Severe Migraines Under Preventive Treatment — NOT_YET_RECRUITING · NA
• Suppressive Functions of Regulatory T Cells in Migraine — NOT_YET_RECRUITING · NA
• Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine — COMPLETED · PHASE3

Refine this search